Promising Thyromimetic Drug Shows Potential For Weight Loss & Cholesterol Reduction
In a recent study, Dr Thayumanavan and his research team investigated the use of a thyromimetic drug, which mimics synthetic thyroid hormone, as a potential solution for weight loss and cholesterol reduction.
In a recent study, Dr Thayumanavan and his research team investigated the use of a thyromimetic drug, which mimics synthetic thyroid hormone, as a potential solution for weight loss and cholesterol reduction. The drug’s unique mechanism of action involves targeting the thyroid hormone receptor beta, predominantly found in the liver, to activate various physiological responses, including fatty acid oxidation and the reverse cholesterol pathway. These findings offer exciting prospects for addressing obesity and high cholesterol levels, although further research is needed to confirm these promising results.
Promising Thyromimetic Drug Shows Potential For Weight Loss & Cholesterol Reduction
#PoweredByYou
We bring you news and stories that are worth your attention! Stories that are relevant, reliable, contextual and unbiased. If you read us, watch us, and like what we do, then show us some love! Good journalism is expensive to produce and we have come this far only with your support. Keep encouraging independent media organisations and independent journalists. We always want to remain answerable to you and not to anyone else.
